Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY: BSX )

96.42 +0.90 (+0.94%)
Official Closing Price Updated: 7:00 PM EDT, Mar 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,790,930
Open 98.04
Bid (Size) 94.76 (1)
Ask (Size) 98.00 (3)
Prev. Close 95.52
Today's Range 96.01 - 98.56
52wk Range 65.52 - 107.17
Shares Outstanding 1,423,852,648
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Goldman Sachs Gains Confidence In Market Rebound, Upgrades GE Healthcare Amid China Recovery Hopes
Goldman Sachs upgrades GE Healthcare to Buy, raising its price target to $100, as analysts see market stabilization and China sales recovering faster than expected. 
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
Via Benzinga

Performance

YTD
+7.88%
+7.88%
1 Month
-9.19%
-9.19%
3 Month
+6.47%
+6.47%
6 Month
+16.25%
+16.25%
1 Year
+42.87%
+42.87%

More News

Read More
2 Reasons to Like BSX (and 1 Not So Much)
Via StockStory
Topics Stocks
Exposures US Equities
ResMed Among Top Stocks For Recent And Long-Term Profit Growth
Via Investor's Business Daily
What To Expect From CooperCompanies’s (COO) Q4 Earnings
Via StockStory
Beyond The Numbers: 17 Analysts Discuss Boston Scientific Stock
Via Benzinga
$1000 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today
Via Benzinga
What Does the Market Think About Boston Scientific?
Via Benzinga
Why the high growth investor may take a look at BOSTON SCIENTIFIC CORP (NYSE:BSX).
Via Chartmill
Boston Scientific To Acquire SoniVie For $400 Million, Expanding Hypertension Treatment Portfolio
Via Benzinga
1 Growth Stock with All-Star Potential and 2 to Brush Off
Via StockStory
Exposures COVID-19
Top Stock Reports For Goldman Sachs, Progressive & Boston Scientific
Via Talk Markets
Topics Stocks / Equities
Medical Devices & Supplies - Diversified Stocks Q4 Teardown: Stryker (NYSE:SYK) Vs The Rest
Via StockStory
Which S&P500 stocks are moving on Tuesday?
Via Chartmill
Explore the top gainers and losers within the S&P500 index in today's session.
Via Chartmill
Q4 Earnings Roundup: Baxter (NYSE:BAX) And The Rest Of The Medical Devices & Supplies - Diversified Segment
Via StockStory
Q4 Earnings Highs And Lows: Neogen (NASDAQ:NEOG) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
Via StockStory
UroGen Pharma Ltd. (NASDAQ: URGN), CS Diagnostics Corp. (OTCQB: CSDX) and Boston Scientific (NYSE: BSX) Advancing Cancer Treatment Technology – More Stocks Inside
Via AB Newswire
Baxter Earnings: What To Look For From BAX
Via StockStory
What To Expect From Baxter’s (BAX) Q4 Earnings
Via StockStory
ResMed Getting Close To Elite Stock Group Entry
Via Investor's Business Daily
Q4 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Boston Scientific (NYSE:BSX)
Via StockStory
Stocks Rebound, Google Eyes Worst Drop In A Year, Gold Shatters Fresh Records: What's Driving Markets Wednesday?
Via Benzinga
GSK Surges 7% After Bumping Its 2031 Outlook To North Of $50 Billion
Via Investor's Business Daily
Boston Scientific Beats Its Own Fourth-Quarter Guidance On Cardiovascular Strength
Via Investor's Business Daily
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.